International Consensus Statement on Screening, Diagnosis and Treatment of Substance Use Disorder Patients with Comorbid Attention Deficit/Hyperactivity Disorder

被引：96

作者：

Crunelle, Cleo L. ^{[1
,2
]}

van den Brink, Wim ^{[3
]}

Moggi, Franz ^{[4
]}

Konstenius, Maija ^{[5
]}

Franck, Johan ^{[5
]}

Levin, Frances R. ^{[6
]}

van de Glind, Geurt ^{[7
]}

Demetrovics, Zsolt ^{[8
]}

Coetzee, Corne ^{[9
]}

Luderer, Mathias ^{[10
]}

Schellekens, Arnt ^{[11
]}

Matthys, Frieda ^{[1
]}

机构：

[1] Univ Ziekenhuis Brussel UZ Brussel, Vrije Univ Brussel, Dept Psychiat, Brussels, Belgium

[2] Antwerp Univ, Toxicol Ctr, Antwerp, Belgium

[3] Univ Amsterdam, Acad Med Ctr, AIAR, Amsterdam, Netherlands

[4] Univ Bern, Univ Hosp Psychiat, Bern, Switzerland

[5] Karolinska Inst, Stockholm, Sweden

[6] Columbia Univ, New York State Psychiat Inst, New York, NY USA

[7] Univ Amsterdam, ICASA Fdn, Amsterdam, Netherlands

[8] Eotvos Lorand Univ, Budapest, Hungary

[9] Univ Limpopo, Dept Pharm, Sovenga, South Africa

[10] Heidelberg Univ, Dept Addict Behav & Addict Med, Cent Inst Mental Hlth, Med Fac Mannheim, Heidelberg, Germany

[11] Radboudumc, Dept Psychiat, Donders Inst Brain Cognit & Behav, NISPA, Nijmegen, Netherlands

来源：

EUROPEAN ADDICTION RESEARCH | 2018年 / 24卷 / 01期

关键词：

Attention deficit/hyperactivity disorder; Substance use disorders; Diagnosis; Treatment; Consensus; DEFICIT HYPERACTIVITY DISORDER; COGNITIVE-BEHAVIORAL THERAPY; RANDOMIZED CONTROLLED-TRIAL; PLACEBO-CONTROLLED TRIAL; SELF-REPORT SCALE; ADULT ADHD; TREATMENT-SEEKING; DOUBLE-BLIND; NONMEDICAL USE; METHYLPHENIDATE;

D O I：

10.1159/000487767

中图分类号：

R194 [卫生标准、卫生检查、医药管理];

学科分类号：

摘要：

Adult attention deficit/hyperactivity disorder (ADHD) often co-occurs with substance use disorders (SUD) and is associated with early onset and more severe development of SUD and with reduced treatment effectiveness. Screening tools allow for a good recognition of possible ADHD in adults with SUD and should be used routinely, followed by an ADHD diagnostic process initiated as soon as possible. Simultaneous and integrated treatment of ADHD and SUD, using a combination of pharmaco- and psychotherapy, is recommended. Long-acting methylphenidate, extended-release amphetamines, and atomoxetine with up-titration to higher dosages may be considered in patients unresponsive to standard doses. This paper includes evidence- and consensus-based recommendations developed to provide guidance in the screening, diagnosis and treatment of patients with ADHD-SUD comorbidity. (c) 2018 S. Karger AG, Basel

引用

页码：43 / 51

页数：9

共 50 条

[31] A Retrospective Comparative Study in Patients With Cocaine Use Disorder Comorbid With Attention Deficit Hyperactivity Disorder Undergoing an rTMS Protocol Treatment
Cardullo, Stefano
Gomez Perez, Luis J.
Cuppone, Diego
Sarlo, Michela
Cellini, Nicola
Terraneo, Alberto
Gallimberti, Luigi
Madeo, Graziella
FRONTIERS IN PSYCHIATRY, 2021, 12
[32] Attention Deficit/Hyperactivity Disorder and Global Severity Profiles in Treatment-Seeking Patients with Substance Use Disorders
Icick, Romain
Moggi, Franz
Slobodin, Ortal
Dom, Geert
Mathys, Frieda
van den Brink, Wim
Levin, Frances R.
Blankers, Matthijs
Kaye, Sharlene
Demetrovics, Zsolt
van de Glind, Geurt
Velez-Pastrana, Maria C.
Schellekens, Arnt S. A.
EUROPEAN ADDICTION RESEARCH, 2020, 26 (4-5) : 201 - 210
[33] Attention Deficit Hyperactivity Disorder and Substance Use Disorder: A Narrative Review
Srichawla, Bahadar S.
Telles, Chloe C.
Schweitzer, Melanie
Darwish, Bilal
CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (04)
[34] Attention Deficit Hyperactivity Disorder and Severity of Substance Use: The Role of Comorbid Psychopathology
Torok, Michelle
Darke, Shane
Kaye, Sharlene
PSYCHOLOGY OF ADDICTIVE BEHAVIORS, 2012, 26 (04) : 974 - 979
[35] The Diagnosis and Treatment of Attention Deficit Hyperactivity Disorder in Patients with Epilepsy
Brown, Mesha-Gay
Becker, Danielle A.
Pollard, John R.
Anderson, Christopher Todd
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2013, 13 (06)
[36] Is substance use disorder with comorbid adult attention deficit hyperactivity disorder and bipolar disorder a distinct clinical phenotype?
Ceraudo, Giuseppe
Toni, Cristina
Vannucchi, Giulia
Rizzato, Salvatore
Casalini, Francesca
Dell'Osso, Liliana
Maremmani, Icro
Perugi, Giulio
HEROIN ADDICTION AND RELATED CLINICAL PROBLEMS, 2012, 14 (03) : 71 - 76
[37] Screening for attention-deficit/hyperactivity disorder in borderline personality disorder
Weibel, Sebastien
Nicastro, Rosetta
Prada, Paco
Cole, Pierre
Rufenacht, Eva
Pham, Eleonore
Dayer, Alexandre
Perroud, Nader
JOURNAL OF AFFECTIVE DISORDERS, 2018, 226 : 85 - 91
[38] Treatment of Attention-Deficit Hyperactivity Disorder
Kim, Young Key
Song, Dong Ho
JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2009, 52 (05): : 489 - 499
[39] Pharmacological treatment of attention-deficit hyperactivity disorder comorbid with an anxiety disorder: a systematic review
Villas-Boas, Camila B.
Chierrito, Danielly
Fernandez-Llimos, Fernando
Tonin, Fernanda S.
Sanches, Andreia C. C.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2019, 34 (02) : 57 - 64
[40] Stimulant treatment for attention-deficit hyperactivity disorder and risk of developing substance use disorder
Groenman, Annabeth P.
Oosterlaan, Jaap
Rommelse, Nanda N. J.
Franke, Barbara
Greven, Corina U.
Hoekstra, Pieter J.
Hartman, Catharina A.
Luman, Marjolein
Roeyers, Herbert
Oades, Robert D.
Sergeant, Joseph A.
Buitelaar, Jan K.
Faraone, Stephen V.
BRITISH JOURNAL OF PSYCHIATRY, 2013, 203 (02) : 112 - 119

← 1 2 3 4 5 →